美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

Adarx Pharmaceuticals, inc

19.94

-0.6950-3.37%

盤後：20.300.3600+1.81%19:30 EDT

成交量：78.88萬

成交額：1,615.71萬

市值：20.38億

市盈率：-2.58

高：21.61

開：20.65

低：19.23

收：20.64

52周最高：23.21

52周最低：18.50

股本：1.02億

流通股本：1.02億

量比：0.35

換手率：0.77%

股息：- -

股息率：- -

每股收益(TTM):-7.7403

每股收益(LYR):-6.4321

淨資產收益率：-38.89%

總資產收益率：-14.90%

市淨率：-8.12

市盈率(LYR):-3.10

資料載入中...

總覽公司新聞資訊公告

公司資料

公司名字：

Adarx Pharmaceuticals, inc

交易所：

NASDAQ

成立時間：

2019

員工人數：

- -

公司地址：

5871 Oberlin Drive,Suite 200,San Diego,California,United States

官網：

http://www.adarx.com

郵編：

92121

電話：

傳真：

- -

簡介：

ADARx Pharmaceuticals, Inc.於2019年12月在特拉華州註冊成立。該公司是一家臨床後期階段的生物技術公司，專註於開發旨在治療廣譜疾病的下一代siRNA療法，推進一系列高效、選擇性和持久的siRNA治療候選藥物，包括三個臨床階段項目和兩個先進的臨床前項目。

董事

名稱

職位

Erez Chimovits

Director and Interim Chairman of the Board

Zhen Li

Chief Executive Officer and Director and President

Carl L. Gordon

Director

Chen Yu

Director

Judith J. Li

Director

Mary Tagliaferri

Director

Ricky Sun

Director

Simeon George

Director

Ting Feng

Director

Ying Huang

Director

股東

名稱

職位

Zhen Li

Chief Executive Officer and Director and President

Ryan Fisk

Chief Business Officer and Chief Financial Officer

A. Robert MacLeod

Chief Scientific Officer

Robert Ackles

Chief People Officer

Rui Zhu

Chief Technology Officer

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/ADRX/company"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"ADRX","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADRX\",,,,,undefined,":{"symbol":"ADRX","market":"US","secType":"STK","nameCN":"Adarx Pharmaceuticals, inc","latestPrice":19.94,"timestamp":1790798400000,"preClose":20.635,"halted":0,"volume":788842,"hourTrading":{"tag":"盘后","latestPrice":20.3,"preClose":19.94,"latestTime":"19:30 EDT","volume":8271,"amount":165443.004,"timestamp":1790811003420,"change":0.36,"changeRate":0.018054,"amplitude":0.019559},"delay":0,"changeRate":-0.03368063968984736,"floatShares":102200905,"shares":102200905,"eps":-7.740306,"marketStatus":"未開盤","change":-0.695,"latestTime":"09-30 16:00:00 EDT","open":20.65,"high":21.61,"low":19.23,"amount":16157101.2861,"amplitude":0.115338,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":-7.740306,"tradingStatus":0,"nextMarketStatus":{"tag":"盤前交易","tradingStatus":1,"beginTime":1790841600000},"marketStatusCode":0,"adr":0,"listingDate":1790308800000,"exchange":"NASDAQ","adjPreClose":20.635,"preHourTrading":{"tag":"盘前","latestPrice":21,"preClose":20.635,"latestTime":"09:14 EDT","volume":178,"amount":3713.5997599999996,"timestamp":1790774086918,"change":0.365,"changeRate":0.017688,"amplitude":0.033923},"postHourTrading":{"tag":"盘后","latestPrice":20.3,"preClose":19.94,"latestTime":"19:30 EDT","volume":8271,"amount":165443.004,"timestamp":1790811003420,"change":0.36,"changeRate":0.018054,"amplitude":0.019559},"volumeRatio":0.352245},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"ADRX\",,,,,undefined,":{"symbol":"ADRX","floatShares":102200905,"roa":"-14.90%","roe":"-38.89%","lyrEps":-6.432121,"volumeRatio":0.352245,"shares":102200905,"dividePrice":0,"high":21.61,"amplitude":0.115338,"preClose":20.635,"low":19.23,"week52Low":18.5,"pbRate":"-8.12","psRate":"332.61","week52High":23.21,"institutionHeld":0,"latestPrice":19.94,"eps":-7.740306,"divideRate":0,"volume":788842,"delay":0,"ttmEps":-7.740306,"open":20.65,"prevYearClose":17,"prevWeekClose":19.35,"prevMonthClose":17,"prevQuarterClose":17,"fiveDayClose":17,"twentyDayClose":17,"sixtyDayClose":17},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/ADRX\",params:#limit:5,,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"ADRX\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"ADRX\",market:\"US\",delay:false,,,undefined,":{},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/ADRX\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"ADRX","date":"2026-09-29","current":-2.576126,"percent":0,"low":-24.41833,"twenty":-24.228516,"median":-23.943795,"eighty":-23.659073,"high":-23.469259,"avg":-23.943795,"sd":0.474535,"marketCap":2145638619},"quantilePoints":[{"date":"2026-09-29","current":-24.41833,"twenty":-24.228516,"median":-23.943795,"eighty":-23.659073,"marketCap":2145638619}],"updateTime":1790826519369},"@#url:\"stock.company.info\",,undefined,":{"stockCompanyProfile":{"companyId":653770897,"yearFounded":2019,"address":"5871 Oberlin Drive,Suite 200,San Diego,California,United States","zipCode":"92121","officePhone":"(877) 232-7974","fiscalYearEnd":"12-31"},"stockCompanyDetail":{"websiteUrl":"http://www.adarx.com","stockEarnings":[{"period":"1week","weight":0.1729},{"period":"ytd","weight":0.1729}],"compareEarnings":[{"period":"1week","weight":-0.0067},{"period":"1month","weight":-0.0058},{"period":"3month","weight":0.024},{"period":"6month","weight":0.1628},{"period":"1year","weight":0.1448},{"period":"ytd","weight":0.1184}],"compareStock":{"symbol":"SPY","name":"標普500ETF"},"description":"ADARx Pharmaceuticals, Inc.於2019年12月在特拉華州註冊成立。該公司是一家臨床後期階段的生物技術公司，專註於開發旨在治療廣譜疾病的下一代siRNA療法，推進一系列高效、選擇性和持久的siRNA治療候選藥物，包括三個臨床階段項目和兩個先進的臨床前項目。","exchange":"NASDAQ","name":"Adarx Pharmaceuticals, inc","nameEN":"ADARx Pharmaceuticals"}},"@#url:\"https://hq.skytigris.cn/fundamental/company/manager/list\",params:#symbol:\"ADRX\",market:\"US\",,,undefined,":{"directors":[{"name":"Erez Chimovits","position":"Director and Interim Chairman of the Board"},{"name":"Zhen Li","position":"Chief Executive Officer and Director and President"},{"name":"Carl L. Gordon","position":"Director"},{"name":"Chen Yu","position":"Director"},{"name":"Judith J. Li","position":"Director"},{"name":"Mary Tagliaferri","position":"Director"},{"name":"Ricky Sun","position":"Director"},{"name":"Simeon George","position":"Director"},{"name":"Ting Feng","position":"Director"},{"name":"Ying Huang","position":"Director"}],"executives":[{"name":"Zhen Li","position":"Chief Executive Officer and Director and President"},{"name":"Ryan Fisk","position":"Chief Business Officer and Chief Financial Officer"},{"name":"A. Robert MacLeod","position":"Chief Scientific Officer"},{"name":"Robert Ackles","position":"Chief People Officer"},{"name":"Rui Zhu","position":"Chief Technology Officer"}]}}}